title: Recurrent Vitreous Hemorrhage Despite Pars Plana Vitrectomy, Laser, and Injections.
authors.affiliation: Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City.
authors.forename: Anthony
authors.initials: A
authors.lastname: Chung
authors.affiliation: Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City.
authors.forename: Eric K
authors.initials: EK
authors.lastname: Chin
authors.affiliation: Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City.
authors.forename: David R P
authors.initials: DR
authors.lastname: Almeida
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D017075:Laser Coagulation; D019654:Lens Implantation, Intraocular / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification; D000069579:Ranibizumab / Q000627:therapeutic use*; D012008:Recurrence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology; D014821:Vitrectomy; D014823:Vitreous Hemorrhage / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab